4.7 Article

Click Chemistry Applied to the Synthesis of Salmonella Typhimurium O-Antigen Glycoconjugate Vaccine on Solid Phase with Sugar Recycling

期刊

BIOCONJUGATE CHEMISTRY
卷 26, 期 12, 页码 2507-2513

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.bioconjchem.5b00521

关键词

-

向作者/读者索取更多资源

A solid-phase conjugation method was developed and applied to the synthesis of an O-antigen based glycoconjugate vaccine against Salmonella Typhimurium, with CRM197 as the carrier protein. Copper-free click chemistry was used as the conjugation chemistry, after derivatizing the sugar and the protein components with alkyne and azido linkers, respectively. This chemistry has the advantage of not deactivating functional groups during the conjugation step, thereby allowing the recycling of unreacted components. The activated carrier protein was adsorbed to an anion exchange matrix and quantitatively conjugated to the O-antigen. The resulting conjugate was eluted from the resin free of unconjugated sugar which was previously removed by simple washing steps. Unreacted O-antigen was recycled by addition to a new batch of resin-CRM197 resulting in further quantitative protein conjugation. This process has advantages in relation to reduction of costs for production of conjugate vaccines, allowing unreacted sugar recovery and simplifying the purification of the glycoconjugate.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Multidisciplinary Sciences

The introduction of a mandatory mask policy was associated with significantly reduced COVID-19 cases in a major metropolitan city

Nick Scott, Allan Saul, Tim Spelman, Mark Stoove, Alisa Pedrana, Alexander Saeri, Emily Grundy, Liam Smith, Michael Toole, Chandini Raina McIntyre, Brendan S. Crabb, Margaret Hellard

Summary: A study in Melbourne, Australia found that the mandatory mask policy led to a significant decline in new COVID-19 cases and a substantial increase in public mask usage during the resurgence of the epidemic. This indicates that masks play a crucial role in controlling epidemics in the broader community.

PLOS ONE (2021)

Article Microbiology

Neisseria meningitidis Factor H Binding Protein Surface Exposure on Salmonella Typhimurium GMMA Is Critical to Induce an Effective Immune Response against Both Diseases

Francesca Necchi, Giuseppe Stefanetti, Renzo Alfini, Elena Palmieri, Martina Carducci, Roberta Di Benedetto, Fabiola Schiavo, Maria Grazia Aruta, Fabiola Giusti, Ilaria Ferlenghi, Yun Shan Goh, Simona Rondini, Francesca Micoli

Summary: This study investigated the immune response differences in heterologous expression of Neisseria meningitidis factor H binding protein (fHbp) in the lumen of Salmonella Typhimurium GMMA. The results showed that formulating fHbp in O-antigen negative GMMA on Alum induced a weak anti-fHbp IgG response in mice. However, chemically conjugating fHbp on the surface of GMMA resulted in a stronger functional response.

PATHOGENS (2021)

Article Biochemistry & Molecular Biology

Novel Simple Conjugation Chemistries for Decoration of GMMA with Heterologous Antigens

Di Benedetto Di Benedetto, Renzo Alfini, Martina Carducci, Maria Grazia Aruta, Luisa Lanzilao, Alessandra Acquaviva, Elena Palmieri, Carlo Giannelli, Francesca Necchi, Allan Saul, Francesca Micoli

Summary: Outer Membrane Vesicles (OMV) offer a promising platform for vaccine development by carrying heterologous antigens and utilizing chemical conjugation for efficient linkage. The use of Generalized Modules for Membrane Antigens (GMMA) as carriers for antigens shows potential for the design of effective vaccines. The conjugation of antigens to GMMA through two different chemistries can induce strong humoral responses and allow for control over the linkage of multiple antigens on the same particle.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Editorial Material Immunology

Critical Needs in Advancing Shigella Vaccines for Global Health

Calman A. MacLennan, Kawsar R. Talaat, Robert W. Kaminski, Dani Cohen, Mark S. Riddle, Birgitte K. Giersing

JOURNAL OF INFECTIOUS DISEASES (2022)

Article Immunology

An adsorption method to prepare specific antibody-depleted normal human serum as a source of complement for human serum bactericidal assays for Salmonella

Matthew K. Siggins, Calman A. MacLennan

Summary: The study demonstrated that incubating human sera with Salmonella preparations can remove pre-existing Salmonella-specific antibodies without affecting serum complement activity. Adsorbed serum, after reconstitution with exogenous specific antibodies, showed bactericidal activity against Salmonella and can be used as a source of human complement for measuring bactericidal activity of Salmonella antibodies.

VACCINE (2021)

Review Immunology

Immunobiology of Carbohydrates: Implications for Novel Vaccine and Adjuvant Design Against Infectious Diseases

Giuseppe Stefanetti, Francesco Borriello, Barbara Richichi, Ivan Zanoni, Luigi Lay

Summary: Carbohydrates play a critical role in immunobiological processes and can be used as antigens or adjuvants in vaccines. However, adjuvants have shown limited ability to improve immune response to carbohydrate-based vaccines in humans. Aluminum salts remain the only authorized adjuvant for carbohydrate-based vaccines.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

Article Immunology

Pivotal Shigella Vaccine Efficacy Trials-Study Design Considerations from a Shigella Vaccine Trial Design Working Group

Patricia B. Pavlinac, Elizabeth T. Rogawski McQuade, James A. Platts-Mills, Karen L. Kotloff, Carolyn Deal, Birgitte K. Giersing, Richard A. Isbrucker, Gagandeep Kang, Lyou-Fu Ma, Calman A. MacLennan, Peter Patriarca, Duncan Steele, Kirsten S. Vannice

Summary: This article discusses the trial design for Shigella vaccines to meet the regulatory requirements and prevent moderate or severe Shigella infections caused by the strains included in the vaccine. The primary endpoint of the vaccine trials is to evaluate the efficacy of the vaccine against the first episode of acute moderate or severe diarrhea.

VACCINES (2022)

Article Microbiology

Genetic and Structural Variation in the O-Antigen of Salmonella enterica Serovar Typhimurium Isolates Causing Bloodstream Infections in the Democratic Republic of the Congo

Sandra Van Puyvelde, Gianmarco Gasperini, Michael Biggel, Marie-France Phoba, Maria Michelina Raso, Tessa de Block, Leen N. Vanheer, Stijn Deborggraeve, Olivier Vandenberg, Nicholas Thomson, Neil Ravenscroft, Calman A. Maclennan, Barbara Bellich, Paola Cescutti, Gordon Dougan, Jan Jacobs, Octavie Lunguya, Francesca Micoli

Summary: Salmonella enterica serovar Typhimurium is a major cause of invasive disease in sub-Saharan Africa, with high levels of antimicrobial resistance. The presence of isolates without the O:5 antigen in recent clinical samples from the Democratic Republic of the Congo suggests the need to consider this antigen variation in vaccine development. This study provides genomic and chemical characterization of the O-antigen features and highlights the evolutionary pressure towards O-antigen variants.
Article Biochemistry & Molecular Biology

Impact of the Host Microbiome on Vaccine Responsiveness: Lessons Learned and Future Perspective

Giuseppe Stefanetti, Dennis L. Kasper

Summary: Vaccination can lead to different immune responses among individuals and populations, and the gut microbiota may play a role in modulating these responses. However, the specific impact of the microbiota on vaccine responsiveness is still unclear, and further research using sophisticated methodologies is needed.

BIOCHEMISTRY (2022)

Article Infectious Diseases

Threshold protective levels of serum IgG to Shigella lipopolysaccharide: re-analysis of Shigella vaccine trials data

Dani Cohen, Shai Ashkenazi, Rachel Schneerson, Nahid Farzam, Anya Bialik, Shiri Meron-Sudai, Valeria Asato, Sophy Goren, Tomer Ziv Baran, Khitam Muhsen, Peter B. Gilbert, Calman A. MacLennan

Summary: This study examined the protective effect of Shigella vaccines and found that a certain level of serum IgG against Shigella lipopolysaccharide (LPS) can predict the degree of protection.

CLINICAL MICROBIOLOGY AND INFECTION (2023)

Review Biochemistry & Molecular Biology

Impact and Control of Sugar Size in Glycoconjugate Vaccines

Giuseppe Stefanetti, Calman Alexander MacLennan, Francesca Micoli

Summary: Glycoconjugate vaccines, which link a carbohydrate antigen to a carrier protein, have been crucial in reducing and controlling bacterial infections. The length of the glycan chain affects the efficacy of these vaccines, and various methods have been used to measure the size of polysaccharide antigens.

MOLECULES (2022)

Article Virology

Comparing Heterologous and Homologous COVID-19 Vaccination: A Longitudinal Study of Antibody Decay

Chiara Orlandi, Giuseppe Stefanetti, Simone Barocci, Gloria Buffi, Aurora Diotallevi, Ettore Rocchi, Marcello Ceccarelli, Sara Peluso, Daniela Vandini, Eugenio Carlotti, Mauro Magnani, Luca Galluzzi, Anna Casabianca

Summary: The humoral response after vaccination was compared in individuals who received different COVID-19 vaccine schedules. Heterologous vaccination induced a stronger immune response than the two homologous vaccinations. The ChAd/BNT vaccine schedule exhibited the longest time of anti-S IgG negativization and slow decay of the titer over time. Factors such as vaccine schedule and BMI had a significant impact on the immune response.

VIRUSES-BASEL (2023)

Article Immunology

Salmonella Combination Vaccines: Moving Beyond Typhoid

Calman A. MacLennan, Jeffrey Stanaway, Stephanie Grow, Kirsten Vannice, A. Duncan Steele

Summary: There is a range of licensed and WHO-prequalified typhoid conjugate vaccines available, but they only address a fraction of the global burden of Salmonella disease. Invasive nontyphoidal Salmonella disease is more common in Africa, while paratyphoid A is a significant cause of enteric fever in Asia. The article explores the need for combination Salmonella vaccines and discusses the potential of a quadrivalent vaccine to provide comprehensive coverage.

OPEN FORUM INFECTIOUS DISEASES (2023)

Review Biochemistry & Molecular Biology

Exploring the variables influencing the immune response of traditional and innovative glycoconjugate vaccines

Francesca Micoli, Giuseppe Stefanetti, Calman A. MacLennan

Summary: Vaccines play a crucial role in reducing infectious diseases, and recent developments in pneumococcal and meningococcal conjugate vaccines emphasize the continued importance of research on glycoconjugate vaccines. Innovative methods like bioconjugation, OMV, and MAPS have been developed to produce carbohydrate-based vaccines. Variables in vaccine design, such as saccharide chain length and conjugation chemistry, carrier protein, and saccharide to protein ratio, can impact immune responses. Understanding the effects of these parameters is essential for designing improved glycoconjugate vaccines.

FRONTIERS IN MOLECULAR BIOSCIENCES (2023)

Article Immunology

Typhoid in India: An Age-old Problem With an Existing Solution

Supriya Kumar, Raj Shankar Ghosh, Harish Iyer, Arindam Ray, Kirsten Vannice, Calman MacLennan, Tanya Shewchuk, Duncan Steele

Summary: The article presents findings from two years of surveillance in India on enteric fever, highlighting the high disease burden and cost of illness. With no universal healthcare coverage in India, patients bear the cost of treatment. Typhoid conjugate vaccines produced by Indian manufacturers offer an immediate solution to this public health problem.

JOURNAL OF INFECTIOUS DISEASES (2021)

暂无数据